Therapeutic effects of chitosan in veterinary dermatology: A systematic review of the literature
- PMID: 33744675
- DOI: 10.1016/j.prevetmed.2021.105325
Therapeutic effects of chitosan in veterinary dermatology: A systematic review of the literature
Abstract
Chitosan is a natural polysaccharide with biocompatibility, biodegradability, nontoxicity, antimicrobial, and hemostatic properties. This biopolymer has been used in different pharmaceutical forms; therefore, it has an attractive potential for dermal applications in veterinary medicine. The aim of this review is to assess the healing potential of chitosan, based on its dermatological effects on animals, to enrich the therapeutic options of veterinary clinicians. A systematic review was conducted based on the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) strategy, retrieving 1,032 studies and selecting 39 after the inclusion and exclusion criteria were applied. The studies included reports with confirmed positive effects (n = 46/99, 46.5 %) (P < 0.05), with positive effects (n = 49.5/99, 49.5 %), and with no effect (n = 4/99, 4 %); none of the studies reported adverse effects. There is an association between frequency of application and a decrease in healing time (P = 0.038); applying chitosan "every 48-72 hours" was the most recommended frequency (n = 10/19, 52.9 %). Chitosan, when applied to skin lesions on animals, produces positive effects on healing, potentially becoming a safe biomaterial for skin treatments in veterinary practice. As an initial protocol, we suggest applying chitosan every 48-72 hours for at least 2 weeks (7 applications).
Keywords: Chitosan; Dermatological effects; Topical treatment; Veterinary science.
Copyright © 2021 Elsevier B.V. All rights reserved.
Similar articles
-
Sertindole for schizophrenia.Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2. Cochrane Database Syst Rev. 2005. PMID: 16034864 Free PMC article.
-
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340. Health Technol Assess. 2006. PMID: 16959170
-
Selegiline for Alzheimer's disease.Cochrane Database Syst Rev. 2003;(1):CD000442. doi: 10.1002/14651858.CD000442. Cochrane Database Syst Rev. 2003. PMID: 12535396
-
Topical clonidine for neuropathic pain in adults.Cochrane Database Syst Rev. 2022 May 19;5(5):CD010967. doi: 10.1002/14651858.CD010967.pub3. Cochrane Database Syst Rev. 2022. PMID: 35587172 Free PMC article.
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
Cited by
-
Therapeutic effects of electrospun chitosan nanofibers on animal skin wounds: A systematic review and meta-analysis.Int J Pharm X. 2023 Mar 1;5:100175. doi: 10.1016/j.ijpx.2023.100175. eCollection 2023 Dec. Int J Pharm X. 2023. PMID: 36950662 Free PMC article. Review.
-
Chitosan Micro/Nanocapsules in Action: Linking Design, Production, and Therapeutic Application.Molecules. 2025 Jan 10;30(2):252. doi: 10.3390/molecules30020252. Molecules. 2025. PMID: 39860124 Free PMC article. Review.
-
Efficacy of chitosan in the treatment of chronic skin lesions in a horse: A case report.Vet Anim Sci. 2022 Jun 29;17:100261. doi: 10.1016/j.vas.2022.100261. eCollection 2022 Sep. Vet Anim Sci. 2022. PMID: 35856003 Free PMC article.
-
Biodegradable Polymers in Veterinary Medicine-A Review.Molecules. 2024 Feb 17;29(4):883. doi: 10.3390/molecules29040883. Molecules. 2024. PMID: 38398635 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials